{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:53:56Z","timestamp":1792205636797,"version":"4.4.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.vaccine.2011.02.058","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T17:24:21Z","timestamp":1299518661000},"page":"3363-3371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Lee H.","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen I.","family":"Pelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Wilder-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.P.","family":"Safadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio A.","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Marc","family":"LaForce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"von Gottberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley A.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.02.058_bib0005","unstructured":"World Health Organization. Weekly epidemiological record. October 4, 2002. Available at: http:\/\/www.who.int\/immunization\/wer7740meningococcal_Oct02_position_paper.pdf [Accessed August 24, 2010]."},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2011.02.058_bib0010","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.2223\/JPED.1612","article-title":"Meningococcal disease and meningitis","volume":"83","author":"Branco","year":"2007","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/adc.85.1.6","article-title":"Neurodevelopmental outcome in meningococcal disease: a case-control study","volume":"85","author":"Fellick","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0020","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/322587","article-title":"Complications of meningococcal disease in college students","volume":"33","author":"Erickson","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0025","doi-asserted-by":"crossref","first-page":"e979","DOI":"10.1542\/peds.2006-0281","article-title":"Multicenter surveillance of invasive meningococcal infections in children","volume":"118","author":"Kaplan","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0030","first-page":"313","article-title":"Enhanced surveillance of epidemic meningococcal meningitis in Africa: a three-year experience","volume":"80","author":"World Health Organization","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0035","unstructured":"Centers for Disease Control. Active Bacterial Core Surveillance (ABCs) Report Emerging Infections Program Network Neisseria meningitidis; 2009. Available at: http:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/mening09.pdf [Accessed August 24, 2010]."},{"key":"10.1016\/j.vaccine.2011.02.058_bib0040","unstructured":"National Advisory Committee on Immunization (NACI): an advisory statement: update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. Canada Communicable Disease Report; April 2009, vol. 36, ACS-3. Available at: http:\/\/www.phac-aspc.gc.ca\/publicat\/ccdr-rmtc\/09pdf\/acs-dcc-3.pdf [Accessed August 24, 2010]."},{"key":"10.1016\/j.vaccine.2011.02.058_bib0045","series-title":"Invasive Neisseria meningitidis in Europe 2006","year":"2006"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2011.02.058_bib0050","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0055","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/JCM.00091-09","article-title":"Genotypic comparison of invasive Neisseria meningitidis serogroup Y isolates from the United States, South Africa, and Israel, isolated from 1999 through 2002","volume":"47","author":"Whitney","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0060","doi-asserted-by":"crossref","DOI":"10.3201\/eid1406.071357","article-title":"Serogroup Y meningococcal disease, Colombia [letter]","author":"Agudelo","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jinf.2009.06.001","article-title":"Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America region","volume":"59","author":"Abad","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0070","unstructured":"Health Protection Agency. Reported deaths due to invasive meningococcal disease by age and calendar year; 2000\u20132008, source ONS. Available at: http:\/\/www.hpa.org.uk\/webw\/HPAweb&HPAwebPrinterFriendly\/HPAweb_C\/1234859709864?p=1201094595391 [Accessed June 22, 2009]."},{"key":"10.1016\/j.vaccine.2011.02.058_bib0075","unstructured":"Czumbel I, Jansson A, Celentano LP, Gauci AA. European Center for Disease Prevention and Control. Epidemiology of invasive meningococcal disease (IMD) in Europe, 2007. Presented at: Virtual Poster Session. Stockholm, Sweden: European Center for Disease Prevention and Control. Available at: http:\/\/www.ecdc.europa.eu\/en\/activities\/diseaseprogrammes\/Eurovaccine\/Documents\/0912-eurovaccine-ID7-Czumbel-inv-meningococcal-disease-Europe-2007.pdf [Accessed November 4, 2010]."},{"key":"10.1016\/j.vaccine.2011.02.058_bib0080","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998\u20132007: implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/INF.0b013e31815c1b3a","article-title":"Risk factors for meningococcal disease in students in grades 9\u201312","volume":"27","author":"Harrison","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0090","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3201\/eid1206.051297","article-title":"Social behavior and meningococcal carriage in British teenagers","volume":"12","author":"MacLennan","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0095","first-page":"499","article-title":"Epidemiology of bacterial meningitis in Niamey, Niger, 1981\u20131996","volume":"77","author":"Campagne","year":"1999","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0100","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pmed.0040101","article-title":"Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight-year longitudinal study in northern Ghana","volume":"4","author":"Leimkugel","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0105","unstructured":"Doen\u00e7a Meningoc\u00f3cica. CASOS, COEF. De incid\u00eancia (por 100.000 hab) e porcentagens de doen\u00e7a meningoc\u00f3cica Segundo faixa et\u00e1ria estado de S\u00e3o Paulo\u20141998 a 2010. Available at: http:\/\/www.cve.saude.sp.gov.br\/htm\/resp\/dm_cfeta.htm [Accessed August 24, 2010]."},{"key":"10.1016\/j.vaccine.2011.02.058_bib0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1179\/016164110X12644252260754","article-title":"Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention","volume":"32","author":"S\u00e1fadi","year":"2010","journal-title":"Neurol Res"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0115","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/501371","article-title":"Maryland Emerging Infections Program. Antigenic shift and increased incidence of meningococcal disease","volume":"193","author":"Harrison","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0120","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Manson lecture meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0125","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jinf.2008.07.014","article-title":"High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W-135:P1.5,2:ST-11 clone in Southern Brazil","volume":"57","author":"Weidlich","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0130","unstructured":"Xiao FL. Personal communication. GMI Summit Meeting, Barcelona, Spain. June 18\u201319, 2010."},{"key":"10.1016\/j.vaccine.2011.02.058_bib0135","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1017\/S0950268808001398","article-title":"Outbreak of meningococcal disease in and around New Delhi, India, 2005\u20132006: a report from a tertiary care hospital","volume":"137","author":"Nair","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0140","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4269\/ajtmh.2009.80.615","article-title":"Increasing isolations of Neisseria meningitidis serogroup A from blood and cerebrospinal fluid in Dhaka, Bangladesh, 1999\u20132006","volume":"80","author":"Hossain","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"#cr-split#-10.1016\/j.vaccine.2011.02.058_bib0145.1","unstructured":"Gupta S and Saha S. Personal communication. GMI Summit Meeting, Barcelona, Spain. June 18-19, 2010"},{"key":"#cr-split#-10.1016\/j.vaccine.2011.02.058_bib0145.2","unstructured":"GMI Steering Committee Meeting, Short Hills Hilton, NJ, United States, November 5-6, 2009."},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2011.02.058_bib0150","doi-asserted-by":"crossref","first-page":"B71","DOI":"10.1016\/j.vaccine.2009.04.070","article-title":"Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis","volume":"27","author":"Stephens","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0155","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1001\/jama.1988.03410180094036","article-title":"Group A meningococcal carriage in travelers returning from Saudi Arabia","volume":"260","author":"Moore","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0160","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.325.7360.365","article-title":"Acquisition of W-135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study","volume":"325","author":"Wilder-Smith","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0165","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1086\/367858","article-title":"Hajj-associated outbreak strain of Neisseria meningitidis serogroup W-135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers","volume":"36","author":"Wilder-Smith","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0170","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(89)90439-X","article-title":"Intercontinental spread of an epidemic group A Neisseria meningitidis strain","volume":"2","author":"Moore","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0175","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1017\/S095026880999104X","article-title":"Emergence and disappearance of W-135 meningococcal disease","volume":"138","author":"Wilder-Smith","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ije\/16.1.91","article-title":"Control of epidemic group A meningococcal meningitis in Nepal","volume":"16","author":"Cochi","year":"1987","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2310\/7060.2002.22452","article-title":"Epidemic meningococcal disease and travel","volume":"9","author":"Pollard","year":"2002","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0190","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/JCM.39.4.1553-1558.2001","article-title":"Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR","volume":"39","author":"Corless","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0195","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4269\/ajtmh.2009.81.475","article-title":"Etiologies of bacterial meningitis in Bangladesh: results from a hospital-based study","volume":"81","author":"Gurley","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0200","series-title":"Poster P041. 17th International Pathogenic Conference (IPNC)","article-title":"The epidemiology and surveillance of meningococcal disease in England and Wales","author":"Gray","year":"2010"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0205","series-title":"Poster P042, 17th International Pathogenic Neisseria Conference (IPNC)","article-title":"Incorporation of RT-PCR into routine public health surveillance for meningococcal meningitis in S\u00e3o Paulo State, Brazil","author":"Sacchi","year":"2010"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0210","series-title":"Control of epidemic meningococcal disease. WHO practical guidelines","author":"World Health Organization","year":"1998"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0215","first-page":"493","article-title":"Pediatric bacterial meningitis surveillance\u2014African region, 2002\u20132008","volume":"58","author":"Centers for Disease Control","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0220","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0225","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1086\/597806","article-title":"Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa","volume":"199","author":"Beernink","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0230","series-title":"Vaccines","article-title":"Meningococcal vaccines","author":"Granoff","year":"2011"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1574-6976.2006.00053.x","article-title":"Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines","volume":"31","author":"Trotter","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0240","unstructured":"National Immunisation Program Schedule, Australia. Available at: http:\/\/www.immunise.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/nips2 [Accessed November 4, 2010]."},{"key":"10.1016\/j.vaccine.2011.02.058_bib0245","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/CVI.00384-09","article-title":"Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine","volume":"17","author":"Borrow","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0250","doi-asserted-by":"crossref","first-page":"B13","DOI":"10.1016\/j.vaccine.2009.04.062","article-title":"Epidemic meningitis due to group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution","volume":"27S","author":"LaForce","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0255","unstructured":"World Health Organization. A new meningitis vaccine for Africa. Available at: http:\/\/www.who.int\/features\/2010\/meningitis_vaccine\/en\/index.html [Accessed February 7, 2011]."},{"issue":"RR-7","key":"10.1016\/j.vaccine.2011.02.058_bib0260","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the advisory committee on immunization practices (ACIP)","volume":"54","author":"Centers for Disease Control","year":"2005","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0265","first-page":"1042","article-title":"Updated recommendation from the advisory committee on immunization practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease","volume":"58","author":"Centers for Disease Control","year":"2009","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0270","unstructured":"Cohn A. Optimizing the Adolescent Meningococcal Vaccination Program. Presentation given at the Advisory Committee on Immunization Practices (ACIP) meeting; October 2010. Available at: http:\/\/www.cdc.gov\/vaccines\/recs\/acip\/downloads\/mtg-slides-oct10\/02-5-mening-mcv4.pdf [Accessed November 12, 2010]."},{"key":"10.1016\/j.vaccine.2011.02.058_bib0275","unstructured":"Velentgas P. Meningococcal Vaccine Study Final Study Result. Available at: http:\/\/www.cdc.gov\/vaccines\/recs\/acip\/downloads\/mtg-slides-jun10\/03-2-mening.pdf [Accessed November 4, 2010]."},{"key":"10.1016\/j.vaccine.2011.02.058_bib0280","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/599117","article-title":"Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents","volume":"49","author":"Jackson","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0285","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/ije\/dyn228","article-title":"Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years","volume":"38","author":"Galloway","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0290","doi-asserted-by":"crossref","first-page":"16","DOI":"10.37757\/MR2007V9.N1.6","article-title":"Cuban meningococcal BC vaccine: experiences and contributions from 20 years of application","volume":"9","author":"Sotolongo Padr\u00f3n","year":"2007","journal-title":"MEDICC Rev"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0295","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0300","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1086\/315833","article-title":"Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992\u20131998","volume":"182","author":"Sacchi","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0305","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0310","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/INF.0b013e3181f59f6d","article-title":"Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2011.02.058_bib0315","doi-asserted-by":"crossref","first-page":"A97","DOI":"10.1016\/j.vaccine.2007.04.049","article-title":"The meningitis vaccine project","volume":"25","author":"LaForce","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0320","unstructured":"Meningitis Vaccine Project. Epidemics in Africa. Available at http:\/\/www.meningvax.org\/epidemics-africa.php [Accessed November 24, 2010]."},{"key":"10.1016\/j.vaccine.2011.02.058_bib0325","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3201\/eid1302.051553","article-title":"Meningococcal disease in South Africa, 1999\u20132002","volume":"13","author":"Coulson","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0330","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/525260","article-title":"Group for enteric, respiratory and meningeal disease surveillance in South Africa. Emergence of endemic serogroup W-135 meningococcal disease associated with a high mortality rate in South Africa","volume":"46","author":"von Gottberg","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0335","unstructured":"Ramsay M, Fox A. Invasive Neisseria meningitidis In Europe 2006. London: Health Protection Agency. Available at: http:\/\/www.euibis.org\/documents\/2006_meningo.pdf [Accessed November 8, 2010]."},{"key":"10.1016\/j.vaccine.2011.02.058_bib0340","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0345","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.inf.0000195594.41449.c6","article-title":"Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands","volume":"25","author":"de Greeff","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0350","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0355","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0360","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/653583","article-title":"Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France","volume":"202","author":"Deghmane","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0365","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.39563.545255.AE","article-title":"Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study","volume":"336","author":"Snape","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0370","first-page":"U1015","article-title":"The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic","volume":"117","author":"Sexton","year":"2004","journal-title":"N Z Med J"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0375","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/aje\/kwm147","article-title":"A prospective study of the effectiveness of the New Zealand meningococcal B vaccine","volume":"166","author":"Kelly","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2011.02.058_bib0380","unstructured":"New Zealand Ministry of Health. Immunisation: meningococcal B (MeNZB\u2122). Available at: http:\/\/www.moh.govt.nz\/moh.nsf\/indexmh\/immunisation-diseasesandvaccines-menzb#start [Accessed August 24, 2010]."},{"key":"10.1016\/j.vaccine.2011.02.058_bib0385","unstructured":"Ministry of Hajj, Kingdom of Saudi Arabia. Important Notices. Visas. Available from: http:\/\/www.hajinformation.com\/main\/p10.htm [Accessed September 24, 2010]."},{"key":"10.1016\/j.vaccine.2011.02.058_bib0390","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1017\/S0950268899002368","article-title":"Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodation","volume":"122","author":"Neal","year":"1999","journal-title":"Epidemiol Infect"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11002933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11002933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:17:32Z","timestamp":1759400252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11002933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":79,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0264410X11002933"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.02.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.02.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011  Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}